Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
Wuhan Easy Diagnosis Biomedicine Co Ltd
Revenue
Wuhan Easy Diagnosis Biomedicine Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
|
Revenue
¥10.5B
|
CAGR 3-Years
287%
|
CAGR 5-Years
130%
|
CAGR 10-Years
N/A
|
|
A
|
APT Medical Inc
SSE:688617
|
Revenue
¥1.7B
|
CAGR 3-Years
51%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Revenue
¥8.6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
17%
|
CAGR 10-Years
20%
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Revenue
¥30.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Revenue
¥9.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
22%
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Revenue
¥9.2B
|
CAGR 3-Years
46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Wuhan Easy Diagnosis Biomedicine Co Ltd's Revenue?
Revenue
10.5B
CNY
Based on the financial report for Dec 31, 2022, Wuhan Easy Diagnosis Biomedicine Co Ltd's Revenue amounts to 10.5B CNY.
What is Wuhan Easy Diagnosis Biomedicine Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
130%
Over the last year, the Revenue growth was 272%. The average annual Revenue growth rates for Wuhan Easy Diagnosis Biomedicine Co Ltd have been 287% over the past three years , 130% over the past five years .